#1 Clinical Trials Search in Europe

Magnesium Chloride Hexahydrate

This article examines several clinical trials investigating the use of Magnesium Chloride Hexahydrate, often in combination with other electrolytes, in various medical procedures. These trials focus on cardiovascular surgeries, heart transplantations, and neurological interventions, exploring the effects of different fluid management strategies and cardioplegia solutions on patient outcomes.

Table of Contents

What is Magnesium Chloride Hexahydrate?

Magnesium chloride hexahydrate is an important electrolyte used in various medical treatments. It is a compound that contains magnesium, chloride, and water molecules. The term “hexahydrate” means it has six water molecules attached to each magnesium chloride molecule[1].

This substance is often found in medical solutions used to maintain proper electrolyte balance in the body. Electrolytes are minerals in your blood and other bodily fluids that carry an electric charge. They are crucial for many bodily functions, including hydration, nerve and muscle function, and maintaining proper pH levels[2].

Medical Uses

Magnesium chloride hexahydrate is used in various medical contexts, including:

  • Electrolyte Solutions: It’s a key component in many intravenous (IV) fluids used to correct electrolyte imbalances or dehydration[3].
  • Cardiac Surgery: Solutions containing this compound are used in heart surgeries, particularly in cardioplegia solutions. These solutions help protect the heart during procedures that require stopping the heart temporarily[4].
  • Organ Preservation: It’s used in solutions designed to preserve organs for transplantation[5].
  • Neurosurgery: Some studies are investigating its use in fluids administered during brain surgeries[6].

How is it Administered?

Magnesium chloride hexahydrate is typically administered in the following ways:

  • Intravenous Infusion: This is the most common method, where the solution is slowly dripped into a vein[7].
  • Intravenous Bolus: In some cases, it may be given as a quicker injection into a vein[7].
  • Organ Perfusion: During organ transplantation or certain surgeries, it may be used to perfuse (flood) an organ with a protective solution[5].

Potential Benefits

The use of magnesium chloride hexahydrate in medical treatments may offer several benefits:

  • Electrolyte Balance: It helps maintain proper levels of essential minerals in the body[2].
  • Cardiac Protection: In heart surgeries, it may help protect the heart muscle from damage during procedures[4].
  • Organ Preservation: It’s part of solutions that help keep organs viable for transplantation[5].
  • Fluid Management: It’s used in solutions that help manage a patient’s fluid levels during and after surgery[6].

Possible Side Effects

While magnesium chloride hexahydrate is generally safe when used as directed by healthcare professionals, it’s important to be aware of potential side effects:

  • Electrolyte Imbalance: If not administered correctly, it could lead to imbalances in other electrolytes[3].
  • Fluid Overload: In some cases, excessive administration of fluids containing this compound could lead to fluid overload[3].
  • Allergic Reactions: Although rare, some individuals may have an allergic reaction to the solution[3].

It’s important to note that these solutions are administered by healthcare professionals who carefully monitor patients for any adverse effects.

Ongoing Research

Several clinical trials are currently investigating the use of solutions containing magnesium chloride hexahydrate:

  • Cardiac Surgery: Studies are comparing different cardioplegia solutions (including those with magnesium chloride hexahydrate) to see which provides better protection for the heart during surgery[4].
  • Neurosurgery: Researchers are looking at how these solutions might affect outcomes in brain surgeries[6].
  • Fluid Management: Some studies are investigating how different fluid management strategies (including those using magnesium chloride hexahydrate) might affect patient outcomes in various types of surgeries[6].

These ongoing studies aim to improve our understanding of how best to use these solutions to benefit patients undergoing various medical procedures.

Trial Focus Key Interventions Primary Outcomes Patient Population
Fluid management in hypovolemia Ringer’s Acetate vs. no intravenous fluids Hemodynamic effects, volume kinetics Healthy volunteers
Post-cardiac arrest treatment Hypertonic sodium lactate vs. Plasmalyte A Brain injury markers, neurological outcomes Comatose cardiac arrest survivors
Fluid therapy in breast reconstruction Goal-directed vs. standard fluid management Perioperative fluid administration, tissue oedema DIEP flap breast reconstruction patients
Fluid management in neurosurgery Goal-directed vs. standard fluid therapy Postoperative complications Elective neurosurgery patients
Pediatric heart transplantation Custodiol-N vs. Custodiol for organ preservation Safety, myocardial protection Children undergoing heart transplantation
Cardioplegia in congenital heart surgery Custodiol-N vs. Custodiol Safety, myocardial protection Children with congenital heart malformations
Cardioplegia in major cardiac surgery Custodiol vs. Buckberg blood cardioplegia Composite of death, AMI, low cardiac output, kidney failure Adults undergoing major cardiac surgery

FAQ

  • What is Magnesium Chloride Hexahydrate used for in these clinical trials? Magnesium Chloride Hexahydrate is used as a component in various solutions for fluid management, organ preservation, and cardioplegia during cardiovascular surgeries, heart transplantations, and neurological procedures.
  • What are some of the main objectives of these clinical trials? The main objectives include evaluating the safety and efficacy of different fluid management strategies, comparing cardioplegia solutions, assessing organ preservation techniques, and investigating the effects on patient outcomes such as complications, recovery time, and mortality rates.
  • What types of patients are typically included in these trials? The trials include a range of patients, from adults undergoing elective surgeries to children with congenital heart defects. Some trials focus on specific age groups, while others have broader inclusion criteria based on the type of medical procedure being performed.
  • What are some of the key outcomes being measured in these trials? Key outcomes include adverse events, cardiac function markers, length of hospital stay, mortality rates, need for post-operative support, and various physiological parameters such as blood pressure, heart rate, and laboratory values.
  • How do these trials compare different treatment approaches? The trials often use randomized, controlled designs to compare different fluid management strategies, cardioplegia solutions, or organ preservation techniques. They may evaluate new formulations against standard treatments or compare multiple established approaches to determine optimal protocols.

Ongoing Clinical Trials on Magnesium Chloride Hexahydrate

  • Effect of sodium hydrogen carbonate on kidney health in critically ill patients with metabolic acidosis and acute kidney injury

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study of Lyophilized Plasma Compared to Standard Fluid Solutions for Patients with Hemorrhagic Shock in the Emergency Room

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Study on the Safety and Effectiveness of PolyCore (Xylitol, L-Carnitine, Polydextrin) for Patients with End-Stage Kidney Disease Starting Peritoneal Dialysis

    Recruiting

    2 1 1
    Investigated drugs:
    Italy

  • Study on Reducing Sodium Chloride and Glucose in Fluids for Critically Ill Patients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study on the Effects of Sodium Lactate and Electrolyte Solution in Comatose Patients After Cardiac Arrest

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study on Human Plasma Protein vs. Crystalloid for Fluid Management in Children with Scoliosis Undergoing Spinal Fusion Surgery

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

  • Study on Peritoneal Ultrafiltration with PolyCore for Patients with Congestive Heart Failure Using Levocarnitine and Drug Combination

    Recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study comparing Custodiol-N and Custodiol organ preservation solutions for heart transplantation in children

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on Fluid Management to Reduce Post-Surgery Complications in Brain Surgery Patients Using Magnesium Chloride, Potassium Chloride, and Sodium Chloride

    Recruiting

    3 1 1 1
    Investigated drugs:
    Czechia

  • Study on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

    Recruiting

    3 1 1 1
    Investigated drugs:
    Denmark Germany Italy Spain Sweden

Glossary

  • Cardioplegia: A technique used in cardiac surgery to temporarily stop the heart by injecting a solution into the coronary arteries. This allows surgeons to operate on a still, bloodless heart.
  • Extracorporeal circulation: A technique that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the body.
  • Hypovolemia: A state of decreased blood volume or fluid loss in the body, which can lead to reduced blood flow and oxygen delivery to tissues.
  • Troponin: A protein released into the blood when heart muscle is damaged. Elevated levels can indicate a heart attack or other cardiac injury.
  • Creatinine kinase (CK-MB): An enzyme found primarily in heart muscle cells. Elevated levels in the blood can indicate damage to the heart muscle.
  • Neuron-specific enolase (NSE): An enzyme used as a marker for neuronal damage. Elevated levels can indicate brain injury.
  • Goal-directed fluid therapy: A method of managing intravenous fluids during surgery based on real-time measurements of a patient's physiological parameters to optimize fluid balance.
  • Aortic cross-clamp: A surgical instrument used to clamp the aorta during heart surgery, temporarily stopping blood flow to the heart.
  • Cardiopulmonary bypass: A technique that temporarily takes over the function of the heart and lungs during surgery, allowing the heart to be stopped.
  • DIEP flap: Deep Inferior Epigastric Perforator flap, a type of breast reconstruction surgery using tissue from the abdomen.

References

  1. http://clinicaltrials.eu/trial/2023-503946-30-00
  2. http://clinicaltrials.eu/trial/2023-506031-15-01
  3. http://clinicaltrials.eu/trial/2023-506152-24-00
  4. http://clinicaltrials.eu/trial/2023-510492-57-00
  5. http://clinicaltrials.eu/trial/2024-511153-21-00
  6. http://clinicaltrials.eu/trial/2024-511517-38-00
  7. http://clinicaltrials.eu/trial/2024-511948-42-00